We prepare stimuli responsive polymeric nanocarrier, RCP-2 to demonstrate the high drug content as well as controlled release in a systematic manner.
No takes yet. Share an insight, caveat, or question.
Mane et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: